Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

958 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Ozkaynak MF, Sahdev I, Gross TG, Levine JE, Cheerva AC, Richards MK, Rozans MK, Shaw PJ, Kadota RP. Ozkaynak MF, et al. Among authors: shaw pj. J Pediatr Hematol Oncol. 2008 Mar;30(3):204-9. doi: 10.1097/MPH.0b013e318162bd0c. J Pediatr Hematol Oncol. 2008. PMID: 18376282 Clinical Trial.
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study Group.
McCowage GB, White L, Carpenter P, Lockwood L, Toogood I, Tiedemann K, Shaw PJ. McCowage GB, et al. Among authors: shaw pj. Med Pediatr Oncol. 1997 Aug;29(2):108-14. doi: 10.1002/(sici)1096-911x(199708)29:2<108::aid-mpo8>3.0.co;2-i. Med Pediatr Oncol. 1997. PMID: 9180912 Clinical Trial.
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.
Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK, Shaw PJ, Haight AE, Grimley M, Grupp SA, Kletzel M, Kadota R. Pulsipher MA, et al. Among authors: shaw pj. Blood. 2009 Aug 13;114(7):1429-36. doi: 10.1182/blood-2009-01-196303. Epub 2009 Jun 15. Blood. 2009. PMID: 19528536 Free article. Clinical Trial.
Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children.
Dandoy CE, Davies SM, Woo Ahn K, He Y, Kolb AE, Levine J, Bo-Subait S, Abdel-Azim H, Bhatt N, Chewning J, Gadalla S, Gloude N, Hayashi R, Lalefar NR, Law J, MacMillan M, O'Brien T, Prestidge T, Sharma A, Shaw P, Winestone L, Eapen M. Dandoy CE, et al. Haematologica. 2021 Jul 1;106(7):1839-1845. doi: 10.3324/haematol.2020.249458. Haematologica. 2021. PMID: 32554562 Free PMC article.
Hematopoietic Stem Cell Transplantation for Hepatitis-associated Aplastic Anemia Following Liver Transplantation for Nonviral Hepatitis: A Retrospective Analysis and a Review of the Literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
Mohseny AB, Eikema DA, Neven B, Kröger N, Shaw PJ, Damaj G, Dalle JH, Bosman PV, Delehaye F, Lankester AC, Smiers FJ, Peffault de Latour R. Mohseny AB, et al. Among authors: shaw pj. J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e1025-e1029. doi: 10.1097/MPH.0000000000001991. J Pediatr Hematol Oncol. 2021. PMID: 33273414 Review.
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
Bhunia N, Abu-Arja R, Stanek JR, Mehyar LS, Shaw PJ, Kang HJ, Stein J, O'Brien TA, Roberts CH, Lee AC, Loeb DM, Ozkaynak MF, Dalal JD, Strahlendorf C, Goyal RK, Shenoy SS, Rangarajan HG. Bhunia N, et al. Among authors: shaw pj. Transfusion. 2021 Mar;61(3):894-902. doi: 10.1111/trf.16260. Epub 2021 Jan 21. Transfusion. 2021. PMID: 33475172
958 results